Status:
COMPLETED
Dose Confirmation Efficacy Study (V260-007)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rotavirus Infections
Eligibility:
All Genders
6-12 years
Phase:
PHASE3
Brief Summary
This study was designed to evaluate the safety of the investigational Rotavirus Vaccine and the efficacy to prevent Rotavirus Gastroenteritis.
Detailed Description
The duration of treatment is 10 months.
Eligibility Criteria
Inclusion
- Healthy infants
Exclusion
- History of abdominal disorders from a birth defect, intussusception, or abdominal surgery
- Known or suspected problems with immune system
- Fever at time of immunization
- Prior administration of a rotavirus vaccine
- History of known prior rotavirus disease
- Chronic diarrhea, or failure to thrive
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2004
Estimated Enrollment :
1312 Patients enrolled
Trial Details
Trial ID
NCT00092443
Start Date
September 1 2002
End Date
June 1 2004
Last Update
September 14 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.